Lydia Loke

Cost‐effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore

Soo-Chin Lee, M. Aziz, F. Pearce, 2020, Cancer reports.

Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer

C. Toh, M. Aziz, Lydia Loke, 2020, Journal of medical economics.

Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore

E. Lim, M. Aziz, Li-Jen Cheng, 2021, Expert review of pharmacoeconomics & outcomes research.